OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
Yannick Vandenplas, Liese Barbier, Steven Simoens, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 13
Yannick Vandenplas, Liese Barbier, Steven Simoens, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 13
Showing 13 citing articles:
An exploration of biosimilar TNF-alpha inhibitors uptake determinants in hospital environments in Italy, Portugal, and Spain
Teresa Barcina Lacosta, Arnold G. Vulto, Isabelle Huys, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 14
Teresa Barcina Lacosta, Arnold G. Vulto, Isabelle Huys, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 14
Patients’ Perceptions of Biosimilars: A Systematic Review
Qiyou Wu, Zhitao Wang, Xin Wang, et al.
BioDrugs (2023) Vol. 37, Iss. 6, pp. 829-841
Closed Access | Times Cited: 13
Qiyou Wu, Zhitao Wang, Xin Wang, et al.
BioDrugs (2023) Vol. 37, Iss. 6, pp. 829-841
Closed Access | Times Cited: 13
Awareness and Knowledge of Biosimilars Among Rheumatologists and Patients
Muhammad Shiraz Niaz, S M Syed Mohamed Suhail, Usama Mahmood
Journal of Health and Rehabilitation Research (2025) Vol. 5, Iss. 1, pp. 1-7
Closed Access
Muhammad Shiraz Niaz, S M Syed Mohamed Suhail, Usama Mahmood
Journal of Health and Rehabilitation Research (2025) Vol. 5, Iss. 1, pp. 1-7
Closed Access
Unaware and unpowered: evaluating patient perceptions and preferences of biosimilars in South Korea
Eunjung Choi, Gyeongseon Shin, SeungJin Bae
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Eunjung Choi, Gyeongseon Shin, SeungJin Bae
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Barriers and Enablers Affecting the Uptake of Biosimilar Medicines Viewed Through the Lens of Actor Network Theory: A Systematic Review
C. Rieger, Judith Dean, Lisa Hall, et al.
BioDrugs (2024) Vol. 38, Iss. 4, pp. 541-555
Open Access | Times Cited: 3
C. Rieger, Judith Dean, Lisa Hall, et al.
BioDrugs (2024) Vol. 38, Iss. 4, pp. 541-555
Open Access | Times Cited: 3
“Biosimilar, so it looks alike, but what does it mean?” A qualitative study of Danish patients' perceptions of biosimilars
Meera Varma, Anna Birna Almarsdóttir, Louise C. Druedahl
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 5, pp. 581-591
Open Access | Times Cited: 14
Meera Varma, Anna Birna Almarsdóttir, Louise C. Druedahl
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 5, pp. 581-591
Open Access | Times Cited: 14
Knowledge, Attitudes and Practice of Healthcare Providers, Healthcare Regulatory Practitioners and Patients Toward Biosimilars in China: Insights From a Nationwide Survey
Yang Hu, Zaiwei Song, Dan Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Yang Hu, Zaiwei Song, Dan Jiang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
A place for biosimilars in the changing multiple sclerosis treatment landscape
Benjamin Greenberg, Gavin Giovannoni
Multiple Sclerosis and Related Disorders (2023) Vol. 77, pp. 104841-104841
Open Access | Times Cited: 6
Benjamin Greenberg, Gavin Giovannoni
Multiple Sclerosis and Related Disorders (2023) Vol. 77, pp. 104841-104841
Open Access | Times Cited: 6
A review of biosimilars in psoriasis: impacts on efficacy, safety, access, and a first-hand look at biosimilar cost savings within the department of veterans affairs
Rebecca R Reese, Shiva Ram Nanavath, Jennifer L. Martin, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Rebecca R Reese, Shiva Ram Nanavath, Jennifer L. Martin, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines
Yannick Vandenplas, Steven Simoens, Florian Turk, et al.
Applied Health Economics and Health Policy (2022) Vol. 20, Iss. 6, pp. 803-817
Open Access | Times Cited: 3
Yannick Vandenplas, Steven Simoens, Florian Turk, et al.
Applied Health Economics and Health Policy (2022) Vol. 20, Iss. 6, pp. 803-817
Open Access | Times Cited: 3
Recommendations for Interchangeability in a Growing Biosimilar Market in Latin America
Gilberto Castañeda‐Hernández, Manuel Espinoza, Luís Pino, et al.
Advances in Therapy (2024) Vol. 41, Iss. 12, pp. 4357-4368
Closed Access
Gilberto Castañeda‐Hernández, Manuel Espinoza, Luís Pino, et al.
Advances in Therapy (2024) Vol. 41, Iss. 12, pp. 4357-4368
Closed Access
Mitigating the Nocebo Effect in Biosimilar Use and Switching: A Systematic Review
Elif Car, Yannick Vandenplas, Teresa Barcina Lacosta, et al.
Pharmaceutical Medicine (2024)
Open Access
Elif Car, Yannick Vandenplas, Teresa Barcina Lacosta, et al.
Pharmaceutical Medicine (2024)
Open Access
